首页|甲状腺乳头状癌颈中央淋巴结转移风险预测

甲状腺乳头状癌颈中央淋巴结转移风险预测

扫码查看
目的 分析甲状腺乳头状癌(papillary thyroid carcinoma,PTC)颈中央淋巴结转移(central lymph node metas-tasis,CLNM)危险因素,构建列线图对其进行CLNM风险预测,为PTC临床诊治提供参考。方法 回顾性分析郑州大学第五附属医院2021年7月-2023年2月121枚结节102例患者的临床资料,分为转移组和未转移组。对比两组患者一般资料,实验室检查,超声及BRAF V600E基因检测结果,筛选独立危险因素,构建列线图模型,绘制受试者工作特征(receiver operating characteristic,ROC)曲线并对模型的效能进行验证。结果 直径大于10。1 mm、TSH大于2。46 mIU/L、边界不清、BRAF V600E阳性是CLNM的独立危险因素,列线图预测CLNM风险AUC为0。816(95%CI 0。741~0。890)。结论 以基于直径、边界、TSH以及BRAF V600E的列线图模型预测CLNM风险效能良好,可为PTC治疗方案制定提供参考。
Risk prediction of cervical central lymph node metastasis in papillary thyroid carcinoma
Objective To analyze the risk factors of cervical central lymph node metastasis in papillary thyroid carcinoma and construct a nomogram to predict the risk of central lymph node metastasis(CLNM),so as to provide reference for clinical diagnosis and treatment of PTC.Methods The clinical data of 121 nodules(102 patients)were analyzed retro-spectively.According to the postoperative pathology and the presence of CLNM,the patients were divided into metastasis group and non-metastasis group.Compare the general data,laboratory examination,ultrasound and BRAFV600E gene detection results of the two groups,screen the independent risk factors and construct the nomogram.,Draw ROC curve and calibration chart to verify the effectiveness of the model.Results Diameter greater than 10.1mm,TSH greater than 2.46 mIU/L,boundary ambiguity,and BRAF V600E positive were independent risk factors for CLNM,and the AUC of the Nomogram was 0.816(95%CI0.741-0.890).Conclusion The nomogram model based on diameter,boundary,TSH and BRAFV600E is of certain value in predicting the risk of CLNM,which can provide reference for the formulation of treatment plan for PTC.

Thyroid papillary carcinomaUltrasoundTSHBRAFV600ENomogram

蒋营浩、傅聿铭、张自森、冯智慧

展开 >

郑州大学第五附属医院普通外科,郑州 450052

郑州大学第五附属医院肿瘤内科,郑州 450052

甲状腺乳头状癌 超声 TSH BRAF V600E 列线图

2024

医药论坛杂志
中华预防医学会,河南省医学情报研究所

医药论坛杂志

影响因子:0.47
ISSN:1672-3422
年,卷(期):2024.45(9)
  • 25